4 results match your criteria: "UCLA and the David Geffen School of Medicine at UCLA[Affiliation]"
Time to Stop Using the Term Relapse in Schizophrenia Clinical Trials.
Schizophr Bull Open
January 2022
Department of Psychiatry, Semel Institute for Neuroscience at UCLA and the David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
My wife's turn in the ICU.
Intensive Care Med
November 2019
Division of Pediatric Critical Care Medicine, Mattel Children's Hospital UCLA and the David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095-1752, USA.
Perspective: a dynamics-based classification of ventricular arrhythmias.
J Mol Cell Cardiol
May 2015
UCLA Cardiovascular Research Laboratory, Department of Medicine (Cardiology), UCLA and the David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors.
View Article and Find Full Text PDFNew developments in medical student education: opportunities for child and adolescent psychiatrists.
J Am Acad Child Adolesc Psychiatry
August 2012
Semel Institute for Neuroscience and Human Behavior at the University of California-Los Angeles (UCLA) and the David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.